Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Pfizer Inc. (NYSE:PFE)

Statement of Comprehensive Income

Beginner level

Pfizer Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net income before allocation to noncontrolling interests 16,302  11,188  21,355  7,246  6,986 
Foreign currency translation adjustments 112  (915) 1,493  (800) (3,200)
Derivative financial instruments (146) 197  (378) (73) (96)
Available-for-sale securities 33  (469) 532  96  (5)
Actuarial gains (losses) (231) (765) 211  (740) 921 
Prior service (costs) credits and other (144) (22) (128) (1) 148 
Benefit plans (375) (787) 83  (741) 1,069 
Other comprehensive income (loss) before allocation to noncontrolling interests (376) (1,974) 1,730  (1,518) (2,232)
Comprehensive income before allocation to noncontrolling interests 15,926  9,214  23,085  5,728  4,754 
Comprehensive (income) loss attributable to noncontrolling interests (18) (16) (62) (27)
Comprehensive income attributable to Pfizer Inc. 15,908  9,198  23,023  5,701  4,755 

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

Comprehensive income item Description The company
Net income attributable to Pfizer Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Pfizer Inc.’s net income attributable to Pfizer Inc. decreased from 2017 to 2018 but then increased from 2018 to 2019 not reaching 2017 level.
Comprehensive income attributable to Pfizer Inc. Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Pfizer Inc.’s comprehensive income attributable to Pfizer Inc. decreased from 2017 to 2018 but then slightly increased from 2018 to 2019.